Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of liposomal doxorubicin in treating children who have refractory solid tumors.

Timeline

Start

1999-07

Primary completion

—

Completion

—

Drugs

Indications